Forecast: Alimentary Tract and Metabolism Medicine Sales in Germany

Based on the forecast data:

  • 2024: $8.31 Billion USD PPP
  • 2025: $8.55 Billion USD PPP
  • 2026: $8.78 Billion USD PPP
  • 2027: $9.01 Billion USD PPP
  • 2028: $9.24 Billion USD PPP

Year-on-Year percentage variations are as follows:

  • 2025 from 2024: 2.89%
  • 2026 from 2025: 2.69%
  • 2027 from 2026: 2.62%
  • 2028 from 2027: 2.55%

The Compound Annual Growth Rate (CAGR) from 2024 to 2028 is approximately 2.68%.

Future trends to watch include the growing incidence of digestive and metabolic disorders, advancements in medical treatments, and the potential impact of healthcare policy changes in Germany. Market demand is expected to continue its steady growth, driven by an aging population and increased healthcare awareness.

Top Countries about Gastrointestinal Drug